Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × HhAntag691 × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Basal Cell 13 Neoplasms 4 Basal Cell Nevus Syndrome 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Medulloblastoma 2 Colorectal Neoplasms 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Pancreatic Diseases 1 Odontogenic Cysts 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Unknown Primary 1 Neoplasms, Basal Cell 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Infratentorial Neoplasms 1

Interventions

Cyclophosphamide 34 fludarabine 29 Tacrolimus 25 Whole-Body Irradiation 22 Mycophenolic Acid 22 Busulfan 21 fludarabine phosphate 19 Melphalan 16 thymoglobulin 14 Antilymphocyte Serum 14 Thiotepa 11 Methotrexate 11 Stem Cell Transplantation 8 Sirolimus 7 Rituximab 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 trametinib 5 ruxolitinib 4 merphos 4 Nivolumab 4 Cytarabine 4 Cyclosporine 4 Cord Blood Stem Cell Transplantation 4 fedratinib 3 ceritinib 3 angiotensin I (1-7) 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Pentostatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡